Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Elbow fracture study aims to uncover hidden causes of chronic pain

NCT ID NCT07259382

Knowledge-focused Sponsor: Université de Montréal Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how inflammation in the nervous system affects pain and recovery after elbow fractures or dislocations. Researchers will take blood samples from 60 adults before and after surgery to measure specific inflammatory markers. The goal is to better understand why some patients develop long-term pain and disability, which could lead to improved treatments in the future.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help identify why some people develop long-term pain and disability after elbow fractures, pointing toward better treatments.
What could go wrong
This is a small, early pilot study with only 60 participants, so results may not apply to everyone. It is designed to gather information, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient with an acute elbow surgery with an appointment at the Hôpital du Sacré-Coeur de Montréal

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults 18 years or older with an acute elbow fracture and/or dislocation less than a week old * Open surgery as the chosen treatment Exclusion Criteria: * Patient with a history of ipsilateral upper limb trauma or pathology, neurological disorder. * Patient unable to answer questionnaires. * Patient unavailable for a one-year follow-up, for example from another country. * Patient with vascular injury or open fracture * Patient with an active inflammatory disease (ex: rheumatoid arthritis) * Patient using anti-inflammatory drugs or immunosuppressants at the time of the injury. * Patient with another acute ipsilateral injury to the upper limb * Polytrauma patients with other injuries than the elbow fracture and concomitant central or peripheral neurological injury.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Elbow dislocation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic Elbow Fractures traumatic brain injury traumatic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Elbow dislocation Elbow fractures Inflammation biomarkers Nerve injury TBI (traumatic brain injury)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.